Protagenic Therapeutics, Inc. ew (OTC:PTIX)
Protagenic Therapeutics, Inc. ew has a live Insider Score.
Scored on 7 qualifying trades from 1 insider in the last 90 days.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- $5.5M
- Net margin
- —
Little or no net debt.
- Total debt
- $0
- Cash
- $566K
- Debt / equity
- 0.00
Owes more within a year than it holds to pay it.
- Current assets
- $710K
- Current liabilities
- $1.1M
- Current ratio
- 0.66
Consumes cash and must keep raising it.
- Operating cash flow
- -$2.6M
- Free cash flow
- -$2.6M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 1.8M
- Share growth (1y)
- -51.1%
- Cash runway
- 3 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
PTIX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | 100.00 % | — | — | — |
| Cost of Revenue | 8.31 K | 11.50 K | 0.00 | 12.57 K | 12.57 K | 12.57 K |
| Gross Profit | -8.31 K | -11.50 K | 0.00 | -12.57 K | -12.57 K | -12.57 K |
| SG&A Expense | 97.98 K | 1.16 M | 154.82 K | 159.91 K | 814.26 K | 567.74 K |
| R&D Expense | 109.92 K | 80.77 K | 153.79 K | 273.23 K | 394.11 K | 880.37 K |
| Operating Expenses | 952.93 K | 1.24 M | 925.10 K | 1.10 M | 2.33 M | 1.45 M |
| Operating Income | -961.25 K | -1.26 M | -925.10 K | -1.11 M | -2.34 M | -1.45 M |
| Pretax Income | -963.62 K | 5.08 M | 2.21 M | -869.50 K | -5.06 M | -1.44 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -963.62 K | 5.08 M | 2.21 M | -869.50 K | -5.06 M | -1.44 M |
| EPS (Basic) | -0.53 | 2.81 | 1.14 | -0.47 | -1.37 | -2.75 |
| EPS (Diluted) | -0.53 | 2.81 | 1.14 | -0.47 | -1.37 | -2.75 |
| Shares Outstanding | 1.81 M | 1.81 M | 1.93 M | 1.85 M | 3.70 M | 3.70 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.